Latest filing published 21 Jul 2025 for Blueprint Medicines Corp.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Ariel Hurley on record concern Blueprint Medicines Corp. The record holds 112 filings, for trades running from 15 March 2019 to 17 July 2025.
On the market, this insider has only sold: 62 sales, €4.9M in total. Besides market trades, the filings include 7 share grants and 41 option exercises. So far in 2025, the count stands at no purchases and 10 sales.
The record was last updated on 21 July 2025 with a transaction in Blueprint Medicines Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations